Human acute leukemia induced pluripotent stem cells: a unique model for investigating disease development and pathogenesis
- PMID: 28725651
- PMCID: PMC5503908
- DOI: 10.21037/sci.2017.05.12
Human acute leukemia induced pluripotent stem cells: a unique model for investigating disease development and pathogenesis
Conflict of interest statement
Conflicts of Interest: P Menendez is an investigator of the Spanish Cell Therapy cooperative network (TERCEL). C Bueno has no conflicts of interest to declare.
Comment on
-
Human AML-iPSCs Reacquire Leukemic Properties after Differentiation and Model Clonal Variation of Disease.Cell Stem Cell. 2017 Mar 2;20(3):329-344.e7. doi: 10.1016/j.stem.2016.11.018. Epub 2017 Jan 12. Cell Stem Cell. 2017. PMID: 28089908 Free PMC article.
Similar articles
-
Generation of a MLL-AF9-specific stem cell model of acute monocytic leukemia.Leuk Lymphoma. 2017 Jan;58(1):162-170. doi: 10.1080/10428194.2016.1180683. Epub 2016 May 17. Leuk Lymphoma. 2017. PMID: 27185517
-
Brief Report: Human Acute Myeloid Leukemia Reprogramming to Pluripotency Is a Rare Event and Selects for Patient Hematopoietic Cells Devoid of Leukemic Mutations.Stem Cells. 2017 Sep;35(9):2095-2102. doi: 10.1002/stem.2655. Epub 2017 Jul 31. Stem Cells. 2017. PMID: 28758276
-
Generation of a human induced pluripotent stem cell line, IMSUTi002-A-1, harboring the leukemia-specific fusion gene ETV6-RUNX1.Stem Cell Res. 2019 Oct;40:101546. doi: 10.1016/j.scr.2019.101546. Epub 2019 Aug 22. Stem Cell Res. 2019. PMID: 31476588
-
Induced pluripotent stem cells: A new strategy to model human cancer.Int J Biochem Cell Biol. 2019 Feb;107:62-68. doi: 10.1016/j.biocel.2018.12.008. Epub 2018 Dec 14. Int J Biochem Cell Biol. 2019. PMID: 30557622 Review.
-
[Induced pluripotent stem cells from leukemia patients as a platform for dissecting pathogenesis].Rinsho Ketsueki. 2014 Oct;55(10):2202-7. Rinsho Ketsueki. 2014. PMID: 25297788 Review. Japanese. No abstract available.
Cited by
-
Genetics and epigenetics of leukemia and lymphoma: from knowledge to applications, meeting report of the Josep Carreras Leukaemia Research Institute.Hematol Oncol. 2020 Oct;38(4):432-438. doi: 10.1002/hon.2725. Epub 2020 Mar 3. Hematol Oncol. 2020. PMID: 32073154 Free PMC article. Review.
-
Evaluation of the safety and efficiency of cytotoxic T cell therapy sensitized by tumor antigens original from T-ALL-iPSC in vivo.Cancer Innov. 2023 Oct 19;3(1):e95. doi: 10.1002/cai2.95. eCollection 2024 Feb. Cancer Innov. 2023. PMID: 38948536 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources